{"id":833847,"date":"2025-04-03T17:03:47","date_gmt":"2025-04-03T21:03:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/"},"modified":"2025-04-03T17:03:47","modified_gmt":"2025-04-03T21:03:47","slug":"praxis-precision-medicines-to-participate-in-upcoming-april-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/","title":{"rendered":"Praxis Precision Medicines to Participate in Upcoming April Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, April  03, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ydvhJ2P9umxyrqLCrOu_l37GAYMDJLFvA_sua9pvK0pp9TQc3uDmVTeiSQClIOIWPGDljBJgT3Wa0I4jhImdhhtMxtNjY2Pdq6Mdw3QZRj2LxoEv4wmgBin1CcdD9L6P\" rel=\"nofollow\" target=\"_blank\"><u>Praxis Precision Medicines<\/u><\/a>, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences this April:<\/p>\n<ul type=\"square\">\n<li>Praxis management will be presenting a corporate overview at the <strong>24<\/strong><sup><strong>th<\/strong><\/sup><strong> Annual Needham Virtual Healthcare Conference<\/strong>, taking place virtually on Monday, April 7, 2025 at 11:00a.m. EDT. A live webcast of the event will be available through this <a href=\"https:\/\/wsw.com\/webcast\/needham146\/register.aspx?conf=needham146&amp;page=prax&amp;url=https:\/\/wsw.com\/webcast\/needham146\/prax\/2275487\" rel=\"nofollow\" target=\"_blank\"><strong>link<\/strong><\/a>.<\/li>\n<li>Praxis management will also be participating in the <strong>Piper Sandler Spring Biopharma Symposium<\/strong>, taking place at One Boston Place in Boston on Thursday, April 17, 2025.<\/li>\n<\/ul>\n<p>The Company will be available for one-on-one meetings during both events. Interested investors should contact their respective Needham and\/or Piper Sandler representatives to request meetings.<\/p>\n<p>Replays of the webcasted events will also be available through the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1wyU21BqzVcZlywM_M3Kiwv2Lt4J6-EQo7GDm0u5Or9Z7VWcOyQzNtUGHPPQ3l84V4AxUqAvLlomdLBQn9dhmVqrhNTu5JYIP-ByI1PY_4I4qxetaLJWexsxFpesQsidZtSDD5AeK9Iwi07Y-CO6bVGGoweqgWqT_e5xkoijMeE=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d page under the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MNGkdspW40VcKGqdsEaJ4k5Twga2pJYeykZe1NKhSL3zCHHwr-C6IoVRCL4ytMNBhva-eCPhv0Vl3JSsjRO_Nanl_BRhmxZqXYcUkaEtfFo=\" rel=\"nofollow\" target=\"_blank\">Investors + Media<\/a>\u201d section of the company\u2019s website for 90 days.<\/p>\n<p>\n        <strong>About Praxis<\/strong>\u202f\u00a0<br \/>Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum\u2122, and antisense oligonucleotide (ASO) platform, Solidus\u2122, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across epilepsy and movement disorders, with four clinical-stage product candidates. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GMUuk8LM8Zm61eaHp1LbJpCRKbkC5YQvQmCKyAUosq1_rZJcXO1R6zxGbBhXD9THBf-9QG5pMhI-ymClsMqpCiAlb6qFMgKHeGUC47w8QusfPlPOQcAz_5ANCvE8uRRCgghaKuC9vEBH1n0ttZN3wBcCa_mTRJ03lwxvXPrmRwzSAwxX1ZD-Ei2tOfp1r1-cEvDzgCG2IXsL__iNp4My8SvuKvOm1HCyarmeuT7Ld7yX8RVcZKjLEBUinqI6zXn9r4ZzlmSeik2oNHqvg0rSgIExuRGVkLFc2S3iZEXoT_kIGkrpSAsZJ43ULUq420VPL7JnozNtPvgRmuELyjJ-QfDzidm9DZK0LGaTiT6SMv4x5CYObJv1ESmnwwhHnh5p__WAmI7mV1S_-qrIwoN0RkfUUpcuQd0J--2CDLoOz3o1TnyztKlGIen7tNfLB625hPGhBRrLirij2TCbRGwd-l4T0wj7stG43IvNZeLck3qiX63S6tKyj3xrST8tBzOD\" rel=\"nofollow\" target=\"_blank\">www.praxismedicines.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RMFijlJddZNcn7eYvabgbo9HviY_7F7m0P5CyUTmIsroyruyRZI_7wYErbgHaOxipNK4OTtgakWJ3OW3NnCyDDQ5pNwoPcxr83ir8nXBu-49F7Ge7j6i46zx86SW_fq9beef41KkNGknA6_eGLFj0VavfDGhX_3IzQlbqs6tW3nipd-YueWUjnxanYU2FQKiSm5upaG5oF67JXCXwTOxLXrV97rkZkBGtNKPWb0r8-q83MzpNBhVz5CJmyqqFgVpdFHTAyjm6sv4UzmeDFMuBefjeQg9O4k-DVUEmurrAcME0fRgNZ5tGGePTUcm1SZFy1FRx0fZCOL00ZxOXc9NUTcWAiV1SJlsU9b2eOtSl4FKmjqQ7Yl0LjRLJCXlNxQQRw88rh5TLtH2ZkCnswDoJsPDGNzTrUHGMDrGyi-qfIHH3qGICBSP6qB8hDqP9YosG3knahJgK_x6Y38h3R3An3fPCFPaOnHraBHExSaOms4=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=usjyi_6YIu-CDztDjiVZvyEpualLvFYacLxcMRZ_Q41m5-u9wO2zNnKiMPLkGPluRxdcHNJq32mTds4kPMHRZp4PKoH09NwO7HwYRMvPnbNntakris4rwuigwPVOFqTHeW0Y5OH9V3g0gZLOjCZ-HeC_s8WOYOhRc38jwCyCMRB4jRoBP1kvCOgGe7W-m4RwVUwnWNCu9DB0Tvp_T-_87h-_187vf3uVG1T041gwQiN-eN4WqAf7M9BZ-dUKl8OQ\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mZN7xxPwGtL2qyLdCDOWtFli8_1k28yQFsD6Yfttlhcp_a0Je-KYQyV4KjNeUXpKNeHvsd904D2SLdAu7383E3nTqOOFO-aw0OLfPvCa4pPHeeN5LaY3c-0AS3VErqs4r6QzKBvC6fE0USm6vkRWXxAlR4pPC-w9bf-U09V6Obd5aIEDjSZ7z41R1P7ua6Rh1Y-NE3i2YCrO7Z2nfG08G0m0GUEbD_BQeDdqkX6Y9sYczCNvMK-hZvuTxqL6Q2_AwVlE76g9gu8gEX3MbvPeONCwik-TjU6Sw69-dr1pO2Qb9ESf0889qHKOjQedaYA1G6n0KmhvHqo3PGb-DhsXTQfulQgjHz_V7g8dD01wC_JQtqRYDPFoocjx4-NsKLjC-W5prpGbCYOuniK1n1P5u3KBfpDLb69fpJ2i68jII_Ror7_s9Kdd0ZcpJjupHvZaNjfZHsthgq_CNby840JjgDupPlSDLDZRhR7svPnTvQ32NZW8oGD3d_LT0UZrcnkTBGIfH3SkwjlawPIaPEp5yg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zZekPMJGh5Uo3e5Hwv4oW465hvgxvNhdZ1q27MlDjynrf6owSamUEZZAgIthH1gUB3N2nQdLHw3gFJJfdrGGoXhIE8SEICtT2mhQo99TriMPouU1MXEeXfkg1GJpJ71qTxzJ05YF4lkQMu_IAbNRoNJm8KbLnGZn2ybPUFbDv3Of7PRlglf5e0_MFMjmzB_ACmFamAvUMnUgqt7xEUmbyC5BCEibgYvzQ6d-5SVr1qByHCHUtN0RuNw5NoUkJn062661m9ElGw0v3UPnyNR0KMqnjUY6whTcaL8lgVgIndMDbTtN5KLyJjxNkdqgPrH4x3Nc6CmVJ-Og0S-2afZZZ2QQ8X7EhsoR9AxbitshqDhDAFxoLX5qIits3o6iluMTXtPRK1meZIoDTF82GoBjKCZyVuva9WQQVYQ1I_xjvYjrsQFr_HrQASOioiFnM-o6\" rel=\"nofollow\" target=\"_blank\">Twitter\/X<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWVmM2Y2OWEtOWQyMS00ZmYxLWIyZTQtMmZiOWNiMGEwMDcxLTEyMTI0NDktMjAyNS0wNC0wMy1lbg==\/tiny\/Praxis-Precision-Medicines-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\u00a0\r\nPraxis Precision Medicines\u00a0\r\ninvestors@praxismedicines.com\u00a0\r\n857-702-9452\u00a0\r\n\u00a0\r\nMedia Contact:\r\nDan Ferry\r\nLife Science Advisors\r\nDaniel@lifesciadvisors.com\r\n617-430-7576<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences this April: Praxis management will be presenting a corporate overview at the 24th Annual Needham Virtual Healthcare Conference, taking place virtually on Monday, April 7, 2025 at 11:00a.m. EDT. A live webcast of the event will be available through this link. Praxis management will also be participating in the Piper Sandler Spring Biopharma Symposium, taking place at One Boston Place in Boston on Thursday, April 17, 2025. The Company will be available &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Praxis Precision Medicines to Participate in Upcoming April Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833847","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences this April: Praxis management will be presenting a corporate overview at the 24th Annual Needham Virtual Healthcare Conference, taking place virtually on Monday, April 7, 2025 at 11:00a.m. EDT. A live webcast of the event will be available through this link. Praxis management will also be participating in the Piper Sandler Spring Biopharma Symposium, taking place at One Boston Place in Boston on Thursday, April 17, 2025. The Company will be available &hellip; Continue reading &quot;Praxis Precision Medicines to Participate in Upcoming April Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T21:03:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Praxis Precision Medicines to Participate in Upcoming April Conferences\",\"datePublished\":\"2025-04-03T21:03:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/\",\"name\":\"Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\",\"datePublished\":\"2025-04-03T21:03:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praxis Precision Medicines to Participate in Upcoming April Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk","og_description":"BOSTON, April 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences this April: Praxis management will be presenting a corporate overview at the 24th Annual Needham Virtual Healthcare Conference, taking place virtually on Monday, April 7, 2025 at 11:00a.m. EDT. A live webcast of the event will be available through this link. Praxis management will also be participating in the Piper Sandler Spring Biopharma Symposium, taking place at One Boston Place in Boston on Thursday, April 17, 2025. The Company will be available &hellip; Continue reading \"Praxis Precision Medicines to Participate in Upcoming April Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-03T21:03:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Praxis Precision Medicines to Participate in Upcoming April Conferences","datePublished":"2025-04-03T21:03:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/","name":"Praxis Precision Medicines to Participate in Upcoming April Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=","datePublished":"2025-04-03T21:03:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQ5OCM2ODQ5ODkzIzIyMDA4OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-april-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Praxis Precision Medicines to Participate in Upcoming April Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833847"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833847\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}